Home > Congress > Session > Session: End of Day 2

Session: End of Day 2

Speakers

Prof. John Weinman

Cem Arkilic, MD

Chief Medical Officer

Abbott, Switzerland

Olivier Gryson

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp

Read more on this topic :

Session: Panel discussion – Sharing reflections and best practice

Session: Congress introduction second day

Session: Panel discussion – Raising adherence as a public health priority

Session: Closing congress first day

Session: Patient perspectives of adherence and how these can help us improve our practice

Session: International Society of Hypertension – Raising awareness on non-adherence

Session: International Society of Gynecological Endocrinology – From treating diseases to treating patients: changing mindsets

Session: Closing congress

Session: Practical individual interventions any healthcare professionals can apply to detect and address non-adherence

Session: The challenge and causes of non-adherence

Session: Consequences of non-adherence to narrow therapeutic index drugs

Session: The paradox of non-adherence to treatment in oncology

Session: Non-adherence is the new cardiovascular risk factor

Session: Welcome and congress introduction

Session: Improving medication adherence with motivational interviewing – example of a heart failure patient

Session: End of Day 1

Session: Why a:care ?

Session: Acting on the unseen: How do we help patients to remain adherent when they are asymptomatic?

Session: The Global Challenge of medication adherence

Session: Introducing the my a:care motivational solution